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The humoral response to transplantation across species includes the produc- 
tion of antibodies specific for the major histocompatibility alloanfigens of the 
donor animal (I-3). In particular, rats immunized with mouse tissues have been 
shown  to  produce  antibodies  reactive  against  a  number  of  individual  //-2 
specificities (1). One possible advantage of this method of production of cyto- 
toxic  anfisera is  the  possibility that  rats may respond to histocompatibility 
atloantigens not detected by other mice, thus providing new genetic markers. 
In the course of analyzing anfisera from a  series of cross-species immuniza- 
tions, an unexpected cytotoxic reaction with  C57B1/10 lymph node cells was 
observed with an antiserum which, according to the current 11-2 chart, should 
have  contained  only specificity for 11-2.31. The results  of additional  studies 
indicate:  (a)  that immunizations between appropriate congenic mouse strains 
produce  altoimmune  antisera  which  likewise  detect  this  new  specificity,  (b) 
that  these  cytotoxic antisera  (hereafter called anfi-"fl")  detect a  cell-surface 
antigen(s)  (hereafter called "/3")  expressed preferentially on  B  cells,  and  (c) 
that tests of recombinant strains indicate  that the gene(s) determining/3 are 
linked to the K-end of the//-2 complex; i.e., in or to the left of the It-1 region. 
Materials and Methods 
Animals.--Adult male mice of all strains  were used. Strains A.SW/Sn, A/J,  AKR/J, 
C57Bl/10Sn,  C57BR/cdJ,  B10.A/SgSn,  B10.D2/nSn, B10.BR/SgSn,  DBA/2J,  LP/J, 
SJL/J,  129/j][, and  C3H.SW/Sn were purchased from Jackson Laboratories, Bar  Harbor, 
Maine.  Strains  A/HeCr,  BALB/cAnCr, CBA/JCr,  C57BI/6Cr,  C3H/HeCr,  C57L/Cr, 
NZB/Cr, B10.A(2R)/Cr, and B10.A(SR)/Cr were obtained from Mr. S. Poiley, Mammalian 
Genetics and Animal Production Section, National Cancer Institute.  Strain B10.A(4R) was 
kindly provided by Dr. R. Lieberman from a breeding colony established from stock origi- 
nated by Dr. J. Stimpfling. Adult male Fischer 344 rats were obtained from the Mammalian 
Genetics and Animal Production Section, National Cancer Institute. 
Immunizations.--Rats were immunized by four weekly intraperitoneal injections of l0  s 
live mouse lymphoid cells (a mixture of single cells prepared from spleens, thymuses, and 
lymph nodes), and were bled by cardiac puncture  1 wk after the fourth immunization (1). 
Mice were immunized by skin grafts according to the method of BiUingham (4), followed by 
several biweekly  intraperitoneal injections of 2 X 107 live lymphoid cells beginning the 3rd wk 
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after skin grafting. They were bled from the tails 1 wk after each intraperitonea| immuniza- 
tion and sera from successive bleedings were pooled. A potent, anti-H-2  b reference antiserum 
was prepared by repeated intraperitoneal immunizations of BALB/c animals with 3  X  107 
lymphoid ceils and lymphoid  tumor cells from C57B1/6 animals.  An anti-0 antiserum was 
prepared by repeated intraperitoneal immunizations of AKR animals with 107 CBA thymus 
ceils, according to the method of Reif and Allen (5). 
Serology.--Trypan  blue cytotoxicity  tests were  performed  in  disposable  U  plates using 
Microdiluters  (Cooke  Engineering Co., Alexandria, Va.)  by the  two-stage method, as pre- 
viously described  (1).  Target cells from mesenteric lymph nodes or  thymuses were gently 
teased  into Medium  199  (Media Unit, National Institutes of Health)  and passed  through 
no. 100 nylon mesh (ToNer, Ernst and Trabler, Inc.; Elmsford, N. Y.) to produce single cell 
suspensions which were then washed and resuspended to 5 X  106/ml in Medium 199 contain- 
ing 0.1% gelatin. Bone marrow and spleen cell suspensions were prepared similarly, except 
that red blood cells were lysed with Tris-buffered ammonium chloride before washing and 
resuspending (6). 
51Cr cytotoxicity tests were performed according to the method of Sanderson  (7).  Cells 
were labeled with 51Cr (Amersham/Searle Corp., Arlington Heights, Ilk) at 300 #Ci/ml at a 
cell concentration of 108/ml, for 40 rain at 37°C in Medium 199. They were then washed three 
times in Medium 199 containing 0.1% gelatin and resuspended in the same medium to a con- 
centration of 5 X  106/ml. Tests were performed in plastic test tubes (Falcon No. 2052, Falcon 
Plastics, Division of Bio Quest, Oxnard, Calif.)  using 50-#l volumes of reagents and of cell 
suspensions. For tests involving treatment of cells with more than one antiserum in succession, 
serum  dilutions were chosen which had previously been determined  to  produce  maximum 
killing of target cells in a standard cytotoxic assay (i.e.,  dilutions on the plateau of the cyto- 
toxic  curve).  Cells  were incubated with the first reagent for 15 min at 37°C,  washed, in- 
cubated with the second reagent for an additional 15 mill at 37°C, washed again, and finally 
treated with 50 #1 of an appropriate dilution of complement for 30 rain at 37°C.  Supernatants 
and pellets from each tube were counted and the percent lysis was calculated according to the 
formula: 
supematant~  supernatant., 
totaln  total~ 
(% lysis).  =  100  X  supernatant,  supernatant~ ' 
total,  total,, 
in which n  =  the experimental tube, m  =  medium control, and z  =  potent H-2 control 
Totals are calculated for each tube as the sum of supernatant and pellet. 
Normal rabbit serum was used as the complement source in both kinds of cytotoxicity 
assays. Rabbit sera with appreciable background cytotoxicity were absorbed according to the 
method of Boyse et al. (8) until two serial twofold dilutions of serum with excess complement 
activity gave less than 10% background lysis. An appropriate complement dilution (usually 
about 1:4) was then selected along the plateau of complement excess. 
Cell suspensions for absorptions were prepared as described above for cytotoxicity studies. 
Appropriate amounts of serum and cells were mixed and incubated at 4°C for 30 rain and then 
centrifuged at 900 g for 15 min. 
Enriched  Subpopulations  of Lymphoid  Cdls.--Cortisone-resistant  thymocytes  were  pre- 
pared  according to  the  method  of  Blomgren and  Svedmyr  (9):  Mice were  treated  intra- 
peritoneally with  125 mg  cortisone acetate  (Upjohn Co.,  Kalamazoo,  Mich.)  per kg  body 
weight 48 h  before  harvesting of thymocytes.  To facilitate removal of parathymic lymph 
nodes,  carbon  black  ("Pelikan,"  Deitzgen,  Eugene  Co.,  Washington,  D.C.)  was  injected 
intraperitoneally 45 rain before sacrificing the animals (10). 
Separation of a mesenteric lymph node cell suspension into populations enriched for T cells 
and for B cells was performed with the kind assistance of Doctors Schwartz and Handwerger DAVID  H.  SACHS AND  JAMES  L.  CONE  1291 
in our laboratory, by a modification of the method of Julius et al.  (11). Briefly, the cell sus- 
pension was incubated with nylon wool according to the published method  (11),  the direct 
effluent consisting of a T-cell-enriched population as determined by fluorescence criteria, using 
a fluoresceinated rabbit anti-mouse IgG. The nylon wool was then mechanically agitated  to 
obtain a  B-cell-enriched population, by the same criteria. This method will be described in 
detail elsewhere) 
RESULTS 
Characterization  of the Reaction.--As  can  be  seen from  the  abbreviated  H-2 
chart in Table I, the only specificity in a  Fischer anti-B10.D2  antiserum which 
one  would  expect  to  survive  exhaustive  absorption  with  B10.A  lymphocytes 
T~LEI 
Abbr~iat~H-gChart 
Strain  H-2  allele 
H-gK region specificities 
1  3  5  8  11  15  16  17  19  20  21  23  25  31"  33  35  36 
BI0.A  a  +  +  +  +  +  -4-  -4- 
Bt0  b  +  +  + 
B10.D2  d  4-  4- 
H-gD region specificities 
I  2  3  4  5  6  7  9  13  18  27  28  29  30  32  35  36  41  42  43 
B10.A  a  --  --  +  +  --  -4-  -4-  --  -4-  +  +  --  --  -4-  4-  +  4-  4- 
BI0  d  --  -4-  +  +  +  +  + 
B10.D2  b  --  --  4-  "4-  --  q-  +  --  +  +  4-  --  --  "4-  4-  4-  4-  4- 
Adapted from distribution charts by Shreftter and Snell (12) and Klein and Shreflter (13). 
* For simplicity we have considered specificity  H-2.34 as an inclusion  of H-2.31, since it would not be 
distinguishable  by any of our sera. 
would  be  anti-H-2.31,  the  so-called  "private  specificity"  of  the  H-2  ~  allele 
(12,  13).  Fischer anti-B10.D2  serum was  absorbed with  1.5  X  109 B10.A lym- 
phocytes  per  ml,  twice  the  number  of  cells  necessary  to  clear  the  serum  of 
cytotoxic activity against lymphocytes of the absorbing strain. Fig.  1 shows the 
cytotoxic  reactions  of  this  absorbed  serum  when  titered  against  splenic  lym- 
phocytes  from  B10.D2  (H-2a),  B10.A  (H-2a),  C57BI/10  (H-2b),  and  A/Jax 
(H-2a).  The  absence  of  reactivity  toward  B10.A  or  A/Jax  cells indicates  the 
completeness of the absorption of species-specific antibodies (1). While the ex- 
pected anti-H-2.31  activity was indeed demonstrable in the reaction with B10. 
D2 cells, there was also residual activity against C57B1/10  (B10)  lyrnphocytes. 
Further  absorption  of  this  serum  with  four  times  this number  of  B10.A  cells 
did not alter the pattern  of these reactions.  2 
1 Handwerger, B. S., and R. H. Schwartz. 1973. Manuscript in preparation. 
2 The initially depressed portion of the cytotoxic curve produced by this absorbed serum 
is probably a  reflection of anticomplementary activity, despite the use of a  two-stage assay 
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The corresponding reactions of a B10.A anti-B10.D2 antiserum are shown in 
Fig. 2. Again there was demonstrable anti-H-2.31  activity but also a  distinct 
reactivity with B10 lymphocytes. For both of these sera, the reaction against 
B10  cells did not reach more than 50%  lysis even at  the most concentrated 
dilutions  of  antiserum.  Furthermore,  fourfold  concentration  of  the  globulin 
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Fla.  1.  Cytotoxicity  assays of  a  Fischer  anti-B10.D2  antiserum  absorbed  with  B10.A 
lymphocytes. In addition to the expected anti-H-2.31 reaction with B10.D2 lymphocytes, an 
unexpected reaction with  C57B1/10 lymphocytes  (anti-~) was  observed.  (Trypan  blue 
method.) 
from these  sera by ultrafiltration  did not increase  the level of killing  of B10 
cells,  indicating  that  only  a  subpopulation  might  be  susceptible  to  lysis. 
Almost identical curves were obtained using lymph node lymphocytes as targets 
except for a  slightly lower maximum percent lysis. 
Since these two antisera were raised against B10.D2  tissues and yet reacted 
with  B10  cells,  the  antigen  being detected  must be present on both B10.D2 
and  B10  cells.  Therefore,  the  corresponding  B10.A  anti-B10  antiserum  was 
prepared and tested against B10.D2 lymphocytes. It showed the same pattern 
of reactivity, with virtually complete killing of B10 cells but only 51% maximal DAVID II.  SAC~S AND JAMES L.  CONE  1293 
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FIG. 2. Cytotoxic assays of a B 10.A anti-B 10.D2 alloantiserum. The reactions are analogous 
to those of Fig.  1 (Trypan blue method.) 
killing of B10.D2 lymph node cells3 The titers  of these sera could not be de- 
creased by additions  of  normal  sera  from  B10,  B10.A,  or  B10.D2  animals, 
indicating that the antigen being detected was not the result of adsorption of 
some serum component to the surface of a portion of the lymphoid cells. 
The congenic resistant  strains of mice presumably differ genetically only at 
11-2 or genes linked  to H-2,  and  therefore  the genes responsible  for this  new 
fl  specificity might  also  be  expected  to be  H-2 linked.  Fortunately  there  are 
several available recombinant B10.A strains with known positions of crossover, 
which were derived during the production of the B 10.A congenic resistant strain 
(14)  and  which make  it possible  to localize the  genes responsible  for/5  with 
respect to the H-2 map. Fig. 3 is a schematic representation of the genetic map 
of the H-2 regions of the H-2  ~ and H-2  b alleles and the correspoinding  recom- 
binant alleles. As can be seen from this diagram, if/3 were determined by genetic 
8 Except where  specifically indicated,  we have  not subtracted  complement  background 
killing from reported percentages of lysis. Thus, for example, in this titer we had a 12% com- 
plement control, indicating that specific maximal lysis by the serum was actually  somewhere 
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material in or to the right of the H-2D region, it should be present in B10.A(2R) 
and in B10.A(4R), but not in B10.A(5R); if it were determined by material in 
or to the left of the It-1 region, it should be present in the B10.A(5R) but not 
in  the  B10.A(2R)  or  B10.A(4R);  other  possible  distributions  would imply 
localization between Ir-1 and the H-2D region. Fig. 4 shows the cytotoxic titers 
of  our  anti-fi alloantiserum with  lymph node  cells  from these  recombinant 
strains. It is apparent that only the B10.A(5R)  recombinant strain possesses 
the fi specificity, indicating localization in or to the left of It-1. 
H-2 
Strain  allele  H-2K  Ir-I  Ir-IgG  Ss-SIp  H-2D 
C 57 B I / I0  b  ~-////////////////////~/~///////////ff//.//////////'//~//ff///////~//////./~ 
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B IOA(SR)  i  ~////////////////////////////////A  I 
FIO. 3. Schematic representation  of the genetic map of B10.A recombinants  of the major 
histocompafibility  complex of the mouse. Shaded portions of the recombinant  alleles repre- 
sent genetic material thought to derive from C57BI/10 (//-2  b) and unshaded portions repre- 
sent the corresponding genetic material from A/J (H-2a). (Adapted from Lieberman [15]). 
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Fro. 4. Cytotoxic assays of anti-~ on lymph node cells from the B10.A recombinants. The 
background complement cytotoxicity for B10.A(4R) cells was 22%. The cytotoxic assay on 
these cells is therefore regarded as negtive. (Trypan blue method.) DAVID  H.  SACHS  AND  JAMES  L.  CONE  1295 
Strain  Distribution.--The  reactivity of  anti-fl with  mesenteric lymph node 
cells from a variety of inbred strains is presented in Table II. Because the B 10.A 
anti-B10.D2 serum (serum 1) contains anti-H-2.31 activity in addition to anti-/3 
activity, reactions  with  cells from animals  bearing  the  H-2  a  allele would not 
TABLE II 
Strain Distribution  of 13 
Strain  H-2 allele  Serum* tested  Complement  Maximum  Specific 
control  % killed  % lysis 
C57B1/10  b  1  9  47  38 
C57B1/6  b  1  12  38  26 
129/J  bc  1  11  29  18 
C3H.SW  b  1  14  34  20 
LP/J  bc  1  12  29  17 
A.BY  b  1  14  63  49 
C57L  b  1  13  43  30 
B10.D2  d  2  12  41  29 
DBA/2  d  2  12  46  34 
BALB/c  d  2  16  57  41 
NZB  d  2  20  54  34 
B10.BR  k  1  11  10  <10 
C57BR  k  1  32  28  <10 
C3H  k  1  13  14  <10 
CBA  k  1  12  11  <10 
AKR  k  1  14  12  <10 
B10.A  a  1,2  15  13  <10 
A/J  a  1,2  19  23  <10 
A/He  a  1,2  8  10  <10 
A.SW  s  1  12  27  15 
SJL  s  1  10  26  16 
B 10.A(2R)  h  1  8  < 10  < 10 
B 10.A(4R)  "h"  1  22  17  < 10 
B 10.A(5R)  i  1  15  43  28 
* Serum 1 =  B10.A anti-B10.D2;  serum 2 =  B10.A anti-B10. 
Cytotoxicity tests were performed by the trypan blue method. 
necessarily imply the presence of/3. The presence or absence of/3 in these strains 
was therefore determined with a  B10.A anti-B10 antiserum (serum 2). 
It is apparent  from this table  that  all of the I1-2 b strains  and  It-2  d strains 
tested were positive for fl and that all of the I-I-2  a strains and It-2  k strains tested 
were negative for/3. Many of these  strains  bearing  the  same H-2  allele were 
independently derived,  or  at  least  separated  for many  generations.  The con- 1296  A  B-CELL  ALLOANTIGEN 
cordance between the presence or absence of/3 and the major/-/-2 allele supports 
the very close linkage of this antigen to the/-/-2 complex. 
Organ distribution.--The maximum percent killing of cell preparations from 
thymus, bone marrow, lymph node, and spleen of B10 animals with our anti-/3 
alloantiserum is shown in Table III. The coresponding percent killing of these 
cell preparations with our reference anti-/-/-2  b antiserum under the same condi- 
tions is also presented for comparison. 
TABLE  III 
Organ Distribution of fl in C57B1/10 
Origin of cell suspension  % lysls in  % lysis in com-  Maximum  %  Maximum  % 
medium control  plement  control  killed  by anti-O killed by anti-//-2 b 
Thymus  < 10  25  27  67 
B one marrow  < 10  11  25  48 
Lymph node  < 10  < 10  47  >  90 
Spleen  < 10  14  49  >  90 
Cytotoxicity tests were performed by  the  trypan blue method. 
The absence of a positive cytotoxic reaction with thymus cells (i.e., less than 
10 % above complement control) cannot, of course, be taken as proof that the 
antigen is not present on those cells, since the density of antigen distribution is 
known  to  affect the  extent of cytotoxic reactivity  (16).  Parallel  absorption 
studies with lymph node and thymus cells from B10 and B10.D2 animals were 
therefore performed. The results are shown in Fig. 5. It is clear that at absorb- 
ing cell concentrations greater than 4  X  108 cells/ml, lymph node cells  were 
able to remove all anti-15 reactivity from the serum, while thymus cells at the 
same concentrations hardly affected this activity. One can estimate from such 
absorptions that thymus cells possess less than 10 % of the/3 antigen of lymph 
node cells. After maximal absorption with B10 lymph node cells, the percentage 
of B10.D2 lymph node cells killed by this dilution of B10.A anti-B10.D2 serum 
was not diminished, indicating that anti-~~-2.31 activity could not be removed 
by B10 cells (i.e., anti-/3  is not a cross-reaction of anti-~~-2.31). 
The  use  of  cortisone-resistant  thymocytes provided  another  approach  to 
the question of whether or not/3 is expressed on thymocytes. Fig. 6 compares 
the anti-~~-2.31 and anti-/3 reactivities of the B10.A anti-B10.D2 antiserum on 
normal and on cortisone-resistant thynlocytes. Reactions with anti-0 antiserum 
are also shown for comparison. While cortisone-resistant B10.D2 cells showed 
an increase in reactivity consistent with the increase in amount of H-2 antigens 
which would be expected on a more mature population of thymocytes (9,  10), 
cortisone-resistant  B10  thymocytes  showed  no  increase  in  reactivity  with 
anti-/3. 
Additional evidence against the presence of/3 on thymus cells was obtained 
using a fluoresceinated anti-K light chain reagent (kindly provided by Dr. Ethan DAVID  H. SACHS AND  JAMES  L. CONE  1297 
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B10 lymph node cells of a  1:8 dilution of B10.A anti-B10.D2 serum after absorption with 
increasing numbers of lymph node or thymus cells. Absorptions with B10 and B10.D2 cell 
suspensions gave comparable results, indicating similar amounts of fl  (means are shown). 
(Trypan blue method.) 
Shevach). B10  thymus cells were first coated with excess anti-/~ or anti-H-2  b, 
then washed and stained with the fluorescent reagent. The percentage of cells 
observed to fluoresce was greater than 90 % among thymocytes first coated with 
anti-H-2  b and less than 10 % among thymocytes first coated with anti-/~. 
Cellular Distribution.--Since ~ appeared to be expressed on only a portion of 
the peripheral lymphocyte populations tested, it was of interest to determine 
whether or not the population bearing this specificity could be correlated with 
other known categories of lymphocytes, namely B and T cells. Lymph node cells 
from B 10 animals were fractionated on nylon columns into populations enriched 
for T  or for B cells (11 and footnote 1). The original cell suspension and each of 
the enriched populations were then tested for cytotoxicity with our anti-j3 allo- 
antiserum and with our reference anti-H-2  b antiserum. The results are shown in 
Table IV,  along with  the  corresponding  percentages of IgG positive cells  (B 
cells)  in  each population  by fluorescence criteria.  The data indicate  that  the 
same subpopulation which  was enriched for B  cells showed a  comparable in- 
crease in percent of cells killed by anti-~. Similarly, the subpopulation which 
was enriched for T  cells showed a  comparable decrease in the level of specific 
killing by anti-j3.  All  three populations  were susceptible  to lysis under  these 
conditions,  as evidenced by the reactions with the anti-H-2  b serum. It is also 
evident from this table that the nonadherent fraction of cells showed a greater 
level of lysis by complement alone than did the adherent fraction.  This may 1298  A  B-CELL ALLOANTIGEN 
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FIG. 6. Comparison of anti-H-2.31 activity and anfi-/~ activity of a B10.A anti-B10.D2 
antiserum tested against normal and cortisone-resistant thymocytes: Anti-H-2.31 activity is 
measured on B10.D2 cells (©  (2)) and anti-B activity on C57B1/10 cells (e ..... e). 
Anti-0 reactions of each cell type are shown for comparisons: B10.D2 ([3  [3), C57BI/10 
(A-- -- --A). 20% cell death was chosen as a lower limit for assays on cortisone-resistant 
thymocytes because of poorer viabilities of these cell preparations in the medium controls. 
indicate that peripheral T  cells, like thymocytes, are more susceptible than B 
cells to natural cytotoxic antibodies in rabbit serum (8). 
Another approach we have taken to determine the cellular distribution of 
has been to study the additivity of anti-/~ to the cytotoxicity of sera of known 
specificity for T  and B  cells. As a  reagent for T  cells we used an alloimmune 
anti-0 serum and as a reagent for B cells we used a rabbit antimouse K-light chain 
antiserum (kindly provided by Dr. R. Mage), the specificity of which had been 
previously demonstrated by others (17, 18). This rabbit antiserum was absorbed 
with 10  ° C57BL/6  thymus cells per ml in an attempt to remove natural cyto- 
toxic activity toward mouse cells. 
The multiple incubations and washes necessary in an additivity study led to DAVID It.  SACHS AND  JAMES L.  CONE  1299 
quantitative losses of cells by the trypan  blue cytotoxicity assay,  presumably 
because  of  swelling  of  dead  cells  which  makes  them  difficult  to  count.  We 
therefore used  a  5~Cr cytotoxicity assay  for  these  studies.  The  results  of  the 
various combinations of antisera tested against B10 lymph node cells are shown 
in Table V. By this assay our anti-~ anti-serum killed 38 %  of the lymph node 
cells. We attribute the high level of killing by the rabbit anti-K serum (62 %) to 
residual natural  cytotoxic antibodies in this serum despite the absorption with 
thymus cells. It is apparent, nevertheless, from these data that anti43 was cap- 
able of increasing the killing by the anti-0 antiserum so that the total cell kill was 
comparable  to  that  caused by addition of the anti-K reagent,  while it did not 
significantly increase the killing due to anti-K. These data thus also suggest that 
/~ is a  B-cell antigen. 
Two other lines of evidence, although  negative, should  also be mentioned. 
When a fluoresceinated anti-K reagent (provided by Dr. Shevach) was employed 
in an experiment similar to that described above for thymus cells, but using B 10 
TABLE IV 
Activities of Fractionated  Lymph Node Cells 
Population from BI0  % Ig pos-  % killed by*  itive (by 
lymph node  fluorescence) Medium  Complement  Anti-~  Anti-H-2  b 
Mixed  32  < 10  < 10  48  >  90 
Nonadherent  (T)  7  <10  37  43  >90 
Adherent  (B)  68  12  17  77  >  90 
* Cytotoxicity tests were performed by the trypan blue method. 
TABLE V 
A dditivity  Studies 
Combination of antisera*  % lysis -4- SE  % increase of lysis  Significance  of increase  at P < 0.05 
0  -[-  0  63.7  4-  1.1  0  -- 
0  q-  K  85.0  4-  3.3  21.3  Yes 
0  -[-  (3  85.6  4-  3.9  21.9  Yes 
K  -[-  K  61.6  ±  3.9  0  -- 
K -k  0  85.0  -4-  3.9  23.4  Yes 
K -4-  fl  68.8  4-  3.6  7.2  No 
Complement  control  =  22.9 -4-  0.3%.  Cytotoxicity tests  were performed  by  the  51Cr 
method. 
* Each value represents the mean of duplicate pairs of assays in which the order of addition 
of reagents was reversed in each pair.  In the case of reactions with anti-K, somewhat higher 
(about  10%) killing was achieved if cells were treated  with this reagent  first rather than in 
the reverse order. This,  and the high percentage  of cells killed by this reagent,  may reflect 
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lymph node cells as targets,  no increase in percentage of cells fluorescing was 
achieved  by prior  incubation  with  anti-~,  while  close  to  100 %  of cells  were 
observed  to fluoresce  after  prior  incubation  with  anti-//-2 b.  Also,  El-4  leu- 
kemia cells (an//-2 b leukemia derived from C57B1/6) were not killed by anti-~ 
under conditions by which the reference anti-//-2 b serum killed more than 90% 
of the cells. This leukemia has been shown by other criteria to be T-cell derived 
(18). While both of these lines of evidence consist of negative rather than posi- 
tive reactions of anti-E, they point out the differences between ~ and other It-2 
linked specificities, and they lend presumptive support to the concept of ~ as a 
B-cell antigen. 
DISCUSSION 
Since  the early descriptions  of the functional dichotomy of lymphoid cells  which 
cooperate in the immune response (19),  a variety of cell-surface markers have been 
described which appear to distinguish the two major categories of cells. In the mouse, 
thymocytes bear one of at least two possible alleles  of the cell-surface antigen-~  (5, 
20) and, in TL+  strains, they also bear the TL surface antigens (20). The 0-antigen, 
unlike  the TL antigens,  is also present on peripheral T  lymphocytes thought to be 
derived from thymocytes. The origin of the other major category of mouse lymphoid 
cells, B cells, is less dear, but they appear to be analogous to the bursal-derived cells 
of the chicken (19). Unlike T  cells, these cells bear readily detectable immunoglobulin 
on their  surface  (21,  22)  and  they can be killed by heterologous anti-K light chain 
antisera  in the presence of complement (17,  18). Immunoglobulin light chains may 
therefore be regarded as a  cell-surface  marker of B  cells.  Another marker has been 
called MBLA (mouse B  lymphocyte antigen)  (23),  an antigen detected by a rabbit 
antimouse lymphocyte serum absorbed exhaustively with thymocytes. By a variety of 
criteria these antibodies have been shown to label and/or kill mouse B cells specifically, 
presumably  via  a  cell-surface marker  distinct  from  immunoglobulin,  since  normal 
mouse serum does not inhibit their binding (23). In addition, an alloantigenic system 
called PC has been described for plasma cells, and the antigens of this system appear 
likewise  to serve  as B-cell markers  (24).  Finally, Ly-4, a  recently described allelic 
antigen  that is not linked to H-2 may also be selectively expressed on B  cells  (25; 
I. F. C. McKenzie, personal communication4). 
Functionally, thymocytes and their derivative T cells are thought to be involved in 
cellular immunity and  to serve  a  "helper"  function in humoral immune responses, 
while B cells are thought to be precursors of antibody-producing cells (26). However, 
it is important to realize that the correlations between the definitions  of these  cell 
populations by surface markers and the functional properties attributed  to each cell 
type may not be precise (27). 
The data presented here appear to reflect the presence of a cell-surface antigen 
expressed preferentially on B  cells. The strain distribution of this antigen indi- 
cates that it is probably part of an allelic system and we are presently attempt- 
ing to define other  alleles  This  antigen  has been called/~,  mainly for ease  of 
presentation.  A  definitive  nomenclature  will  require  further  investigation  of 
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the other possible alleles of this antigen and of their relationship, if any, to 
H-2 and Ir region products (28). 
/~ appears to be determined by genetic material distinct from that responsible 
for any other known B-cell antigens. In particular,  the genetic data indicate 
that the gene(s) responsible for fl are localized in or to the left of the Ir-1 region 
of the major histocompatibility complex. Since known heavy and light chain 
genes are not linked genetically to H-2, and since normal B10 serum did not 
inhibit the reactivity of our anti-/3 sera, it seems unlikely that/3 is an immuno- 
globulin-related marker.  5 MBLA is thought to be a  "species-specific" antigen 
rather than an allelic system, and its genetic localization is not known (23). PC 
and Ly-4, although allelic systems, have been shown not to be linked to H-2, and 
their  strain distributions are  distinct from that of ~  (24,  25).  As for T-cell 
markers, only TL has been shown to be H-2 linked; but the genetic material 
responsible for this antigen has been mapped to the right of the H-2D region, 
and it is therefore quite distant from the genetic material responsible for/3 (20). 
It is interesting that the percentage of lymph node cells killed by anti-/~ re- 
actions in different strains seems to vary considerably (Table II). Part of this 
variability may be due to variability in the proportions of relative cell types in 
the lymph nodes of different animals of the same strain (29),  which we have 
noted to account for as much as i10%  in the reactions of anti-/~ with lymph 
node cells from normal  C57B1/10  animals. There may also be  strain-related 
differences in the proportion of B cells in different lymphoid organs (17). Finally, 
part of the variability may reflect strain-related differences in susceptibility to 
the natural antibodies in rabbit complement, since we have found reproducibly 
higher complement backgrounds in certain strains.  Since T  cells  seem to be 
more susceptible to the effects of complement toxicity than do B  cells  (vide 
supra) it might be reasonable to subtract complement backgrounds from our 
reported percentages of maximal lysis by anti-B in order to determine the actual 
percentage of B cells in each lymph node population. For completeness, how- 
ever, we have reported both values (Table II). 
It was of some concern that this specificity had not previously been found in 
anti-H-2.31  antisera.  However,  the  usual  manner  of  producing  anti-H-2.31 
antisera  involves immunization of  (B10  X  A)F1  recipients  with  lymphoid 
tissues from B10.D2  animals (30).  Unlike the B10.A, such hybrid recipients 
would possess/3 and would therefore not produce cytotoxic antibodies against it. 
Furthermore, it is likely that reactions similar to anti-fl have been observed 
previously during the production of other "monospecific" antisera but, due to 
their low maximal percent lysis and/or titers, have been regarded as "cross- 
reactions" rather than as antibody specificities to antigens present on a  sub- 
population of lymphoid cells (31). 
5  However, cell-surface  antibody may contain structural differences,  as yet undetermined, 
from humoral antibody, and such differences  could  conceivably  be encoded  by distant genetic 
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Davies has recently described  the antigenic specificity  H-2.46  on the basis of the 
cytotoxic reactions of an A/Jax anti-B10  antiserum with a  variety of strains  (32). 
The strain distribution reported for this specificity  is not incompatible with that of 
our anti-/3 specificity.  However, the serum may also have contained non-H-2 speci- 
ficities,  and no data were presented on the maximal percent lysis obtained. It is of 
course possible that a variety of H-2 linked antigens exist which  are expressed  pref- 
erentially on either T or B cells. For example, Hauptfeld et al. have recently described 
an antiserum which purportedly reacts with an antigen specific to T  cells (33). Their 
data indicate that this specificity is determined by genetic information in the Ir region 
of  the  major  histocompatibility  complex.  We  are  presently  investigating  possible 
functional correlations  for/3 such as cellular cytotoxicity, induction of second-set  skin 
rejection, and effects of anti-/3 sera on the immune response in vitro. It would likewise 
seem reasonable to determine the functional relationship between the T-ceU specificity 
described  by Hauptfeld et al. and  Ir gene  functions  before calling  that  specificity 
"Ir-l.l"  as they have suggested  (33). 
It-2 antigens previously have always been found on all lymphoid cells rather 
than selectively distributed on subpopulations. There is probably, therefore,  a 
qualitative difference between these new tt-2 linked T- and B-cell antigens  and 
the classical H-2 antigens. In this regard it is interesting to note that  Shevach 
et al. have recently reported that alloantisera produced by reciprocal immuniza- 
tion of strain 2 and strain 13 guinea pigs appear to be preferentially cytotoxic to 
B cells (34). While they interpret their data as reflecting a higher  concentration 
of histocompatibility antigens  on B  cells  than on T  cells,  they point out the 
possibility  that  their  antisera  may in  fact recognize  B-lymphocyte antigens 
rather  than  histocompatibility antigens  in  the usual  sense. In any case,  it is 
interesting  that  guinea pig alloantisera,  across what is by other criteria (e.g., 
MLC and It)  a major histocompatibility locus, appear to react preferentially 
with a subpopulation of lymphoid cells.  It suggests that lymphoid differentia- 
tion antigens may be found associated with the major histocompatibility com- 
plexes of a variety of species if they are intentionally sought. 
SUMMARY 
Antibodies cytotoxic for only a subpopulation of C57B1/10 lymph node and 
spleen cells were detected when rat antiserum against B 10.D2 was exhaustively 
absorbed with B10.A lymphocytes. Antibodies of similar specificity were also 
detected in B10.A anti-B10.D2  and in B10.A anti-C57Bl/10  alloantisera.  Re- 
actions with recombinant strains of mice indicate that the cell-surface antigen(s) 
responsible for this specificity is determined by gene(s) in or to the left of the It-1 
region  of the major histocompatibility complex. A variety of criteria implicate 
B  cells as the subpopulation of lymphocytes bearing this antigen. In view of 
these data and the recent report by others of a T-cell alloantigen determined by 
gene(s)  in  the major histoeompatibility complex, it seems possible that there 
may be a  variety of H-2-1inked alloantigens  expressed preferentially on  sub- 
classes of lymphocytes. DAVID H.  SACHS AND  JAMES L.  CONE  1303 
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